Trending Topics

Trending Topics

153 Trending Topics found

Design and Construction of the David H. Koch Center for Cancer Care Recognized by Industry Leaders

The David H. Koch Center for Cancer Care has recently been recognized by a number of industry leaders for its innovative and resilient design, some of the many features that put the 750,000 square foot facility in a class of its own.

  • Friday, June 5, 2020

Dr. Solit on Actionable Cancer Genomes in “MSK Science Spotlight”

David Solit, MD, Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, is the featured speaker for the June 3 episode of “MSK Science Spotlight.”

  • Wednesday, June 3, 2020

Dr. Massagué to Host June 1 “MSK Science Spotlight” featuring Dr. Ron Vale

June’s “MSK Science Spotlight” segments kick off on Monday, June 1, featuring the honoree of the Katharine Berkan Judd Award Lectureship, Ron Vale, PhD, Vice President and Executive Director, Janelia Research Campus at the Howard Hughes Medical Institute.

  • Monday, June 1, 2020

ASCO 2020: First Comprehensive Assessment Highlights the Importance of Germline Analysis in Advanced-Cancer Patients

During the upcoming ASCO Virtual Scientific Program, MSK Medical Oncologist Zsofia K. Stadler, MD, will present a study where she and her team sought to assess the clinical utility of germline mutation profiling for targeted therapeutic interventions in a pan-cancer patient population, or a population with similarities and differences among the genomic and cellular alterations found across their diverse tumor types.

  • Friday, May 29, 2020

ASCO 2020: Advances in the Treatment of Small-Cell Lung Cancer

During the upcoming ASCO Virtual Scientific Program, MSK Chief of Thoracic Oncology Service Charles M. Rudin, MD, PhD, will present a study that found pembrolizumab addition to first-line chemotherapy significantly improved progression-free survival for patients with small cell lung cancer (SCLC).

  • Thursday, May 28, 2020

ASCO 2020: Using Acupuncture to Treat Pain in Cancer Survivors

During the upcoming ASCO Virtual Scientific Program, MSK Chief of Integrative Medicine, Jun J. Mao, MD, MSCE will be presenting a new study comparing the effectiveness of electro-acupuncture (EA) and auricular acupuncture (AA) versus usual care (UC) for chronic musculoskeletal pain in cancer survivors.

  • Thursday, May 28, 2020

ASCO 2020: MSK Experts Featured at the Virtual Scientific Program

Thousands of oncology experts from around the world will tune in May 29-31 for the American Society of Clinical Oncology’s (ASCO) Virtual Scientific Program. MSK physicians and scientists are involved in notable research to be presented at the meeting.

  • Wednesday, May 27, 2020

Creating a Safe Space for Cancer Surgery

Concerns around COVID-19 are common in the general population, but cancer patients are also balancing questions about what the pandemic means for their treatment, prognosis, and vulnerability to the virus.

  • Wednesday, May 27, 2020

Targeted Therapy Selpercatinib Approved for Lung and Thyroid Cancers with RET Gene Mutations or Fusions

The U.S. Food and Drug Administration (FDA) recently granted accelerated approval to selpercatinib (Retevmo™) for lung and thyroid cancers with RET (REarranged during Transfection) gene mutations or fusions.

  • Tuesday, May 26, 2020

MSK Science Spotlight: Gene Therapy for Genetic Disease

The May 20 installment of “MSK Science Spotlight” will feature guest speaker, Katherine High, MD, Professor Emerita, Perelman School of Medicine of the University of Pennsylvania; Co-founder and former President and Head of R&D, Spark Therapeutics.

  • Wednesday, May 20, 2020